20 monthly gift articles to share
CRISPR–Cas9 screening identifies CLCC1 as a factor that increases neutral lipid flux to prevent hepatic steatosis and promotes nuclear pore complex assembly by promoting membrane bending and fusion.
，推荐阅读谷歌浏览器下载获取更多信息
Екатерина Грищенко (старший редактор отдела «Бывший СССР»)
Ditch the doldrums"Turn on my happy routine."